- Home
- MMT vs ADCT Comparison
MMT vs ADCT Comparison
Compare MMT & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MMT
- ADCT
- Stock Information
- Founded
- MMT 1987
- ADCT 2011
- Country
- MMT United States
- ADCT Switzerland
- Employees
- MMT N/A
- ADCT N/A
- Industry
- MMT Trusts Except Educational Religious and Charitable
- ADCT Biotechnology: Pharmaceutical Preparations
- Sector
- MMT Finance
- ADCT Health Care
- Exchange
- MMT Nasdaq
- ADCT Nasdaq
- Market Cap
- MMT 270.5M
- ADCT 260.9M
- IPO Year
- MMT N/A
- ADCT 2020
- Fundamental
- Price
- MMT $4.80
- ADCT $3.14
- Analyst Decision
- MMT
- ADCT Strong Buy
- Analyst Count
- MMT 0
- ADCT 5
- Target Price
- MMT N/A
- ADCT $8.00
- AVG Volume (30 Days)
- MMT 86.5K
- ADCT 293.2K
- Earning Date
- MMT 01-01-0001
- ADCT 11-05-2024
- Dividend Yield
- MMT 8.58%
- ADCT N/A
- EPS Growth
- MMT N/A
- ADCT N/A
- EPS
- MMT 0.30
- ADCT N/A
- Revenue
- MMT N/A
- ADCT $66,745,999.00
- Revenue This Year
- MMT N/A
- ADCT $6.58
- Revenue Next Year
- MMT N/A
- ADCT $14.28
- P/E Ratio
- MMT $15.33
- ADCT N/A
- Revenue Growth
- MMT N/A
- ADCT N/A
- 52 Week Low
- MMT $4.04
- ADCT $0.36
- 52 Week High
- MMT $4.70
- ADCT $6.04
- Technical
- Relative Strength Index (RSI)
- MMT 37.80
- ADCT 51.84
- Support Level
- MMT $4.84
- ADCT $2.93
- Resistance Level
- MMT $4.89
- ADCT $3.28
- Average True Range (ATR)
- MMT 0.03
- ADCT 0.20
- MACD
- MMT -0.01
- ADCT 0.00
- Stochastic Oscillator
- MMT 0.00
- ADCT 56.00
About MMT MFS Multimarket Income Trust
MFS Multimarket Income Trust is a diversified closed-end management investment company. Its investment objective is to seek high current income, but may also consider capital appreciation. The fund invests a majority of its net assets in fixed-income securities, corporate bonds of the U.S and foreign issuers, U.S Government securities, foreign government securities, mortgage-backed and other asset-backed securities of U.S and foreign issuers, and debt instruments of issuers located in emerging market countries. The portfolio of investments comprises of different sector investments such as aerospace, airlines, automotive, chemicals, electronics, and others.
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.